LTC1781298I2 - Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui - Google Patents

Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui

Info

Publication number: LTC1781298I2
Authority: LT; Lithuania
Prior art keywords: treatment; pharmaceutical compositions; compositions containing; respiratory diseases; containing benzoxazine
Prior art date: 2004-04-22

Application number

LTPA2015043C

Other languages

English (en)

Original Assignee

Boehringer Ingelheim International Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-22

Filing date

2015-12-01

Publication date

2018-09-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34966478&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LTC1781298(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-04-22 Priority claimed from DE102004019540A external-priority patent/DE102004019540A1/de

2004-11-03 Priority claimed from DE102004052987A external-priority patent/DE102004052987A1/de

2015-12-01 Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh

2018-09-25 Publication of LTC1781298I2 publication Critical patent/LTC1781298I2/lt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Transplantation (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Rheumatology (AREA)
Virology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

LTPA2015043C 2004-04-22 2015-12-01 Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui LTC1781298I2 (lt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DE102004019540A DE102004019540A1 (de)	2004-04-22	2004-04-22	Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
DE102004052987A DE102004052987A1 (de)	2004-11-03	2004-11-03	Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
EP05002496		2005-02-07
PCT/EP2005/004073 WO2005102349A1 (de)	2004-04-22	2005-04-18	Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen
EP05739576A EP1781298B1 (de)	2004-04-22	2005-04-18	Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen

Publications (1)

Publication Number	Publication Date
LTC1781298I2 true LTC1781298I2 (lt)	2018-09-25

Family

ID=34966478

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTPA2015043C LTC1781298I2 (lt)	2004-04-22	2015-12-01	Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui

Country Status (32)

Country	Link
EP (2)	EP2422786B1 (lt)
JP (1)	JP2007533683A (lt)
KR (2)	KR20130049840A (lt)
AR (1)	AR049262A1 (lt)
AT (1)	ATE539754T1 (lt)
AU (1)	AU2005235419B2 (lt)
BE (1)	BE2015C065I2 (lt)
BR (1)	BRPI0510080B8 (lt)
CA (1)	CA2559699C (lt)
CY (3)	CY1113890T1 (lt)
DK (2)	DK1781298T3 (lt)
EA (1)	EA013157B1 (lt)
EC (1)	ECSP066947A (lt)
ES (2)	ES2523518T3 (lt)
FI (1)	FIC20170005I1 (lt)
HU (1)	HUS1500058I1 (lt)
IL (2)	IL177685A (lt)
LT (1)	LTC1781298I2 (lt)
LU (1)	LU93066I2 (lt)
MY (1)	MY148945A (lt)
NL (1)	NL300779I2 (lt)
NO (2)	NO337714B1 (lt)
NZ (1)	NZ550797A (lt)
PE (1)	PE20060462A1 (lt)
PL (2)	PL1781298T4 (lt)
PT (2)	PT1781298E (lt)
SG (1)	SG152237A1 (lt)
SI (2)	SI1781298T1 (lt)
TW (2)	TWI374739B (lt)
UY (1)	UY28861A1 (lt)
WO (1)	WO2005102349A1 (lt)
ZA (1)	ZA200606624B (lt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7056916B2 (en)	2002-11-15	2006-06-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments for the treatment of chronic obstructive pulmonary disease
DE102004024452A1 (de) *	2004-05-14	2005-12-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosolformulierung für die Inhalation von Betaagonisten
US7220742B2 (en)	2004-05-14	2007-05-22	Boehringer Ingelheim International Gmbh	Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US7923455B2 (en) *	2005-01-28	2011-04-12	Boehringer Ingelheim International Gmbh	Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic
JP2008530177A (ja) *	2005-02-16	2008-08-07	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	抗コリン作用薬及びエチプレドノールを含有する医薬組成物
BRPI0614410A2 (pt)	2005-08-15	2011-03-29	Boehringer Ingelheim Int	processo para preparação de betamiméticos
TWI396541B (zh) *	2005-10-10	2013-05-21	Boehringer Ingelheim Int	用於治療呼吸疾病之新穎藥物組合
TWI389692B (zh) *	2005-10-10	2013-03-21	Boehringer Ingelheim Int	用以吸入β-共效劑的氣溶膠調配物
ATE529399T1 (de)	2005-11-10	2011-11-15	Nicholas S Bodor	Sanfte anticholinerge ester
WO2007093608A1 (de) *	2006-02-16	2007-08-23	Boehringer Ingelheim International Gmbh	Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
ATE505193T1 (de) *	2006-08-07	2011-04-15	Boehringer Ingelheim Int	Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
UY30543A1 (es) *	2006-08-18	2008-03-31	Boehringer Ingelheim Int	Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) *	2006-08-18	2008-03-31	Boehringer Ingelheim Int	Formulacion de aerosol para la inhalacion de agonistas beta
EP2086641A2 (en) *	2006-10-26	2009-08-12	Boehringer Ingelheim International GmbH	Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders
EP1921070A1 (de)	2006-11-10	2008-05-14	Boehringer Ingelheim Pharma GmbH & Co. KG	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
BRPI0907916A2 (pt)	2008-02-07	2015-07-28	Boehringer Ingelheim Int	Heterociclos espirociclos, medicamentos contendo esses compostos, e processos para preparar os mesmos
CA2733153C (en)	2008-08-08	2016-11-08	Boehringer Ingelheim International Gmbh	Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
EP2370053A1 (de) *	2008-11-27	2011-10-05	Boehringer Ingelheim International GmbH	Neue pulverförmige kristalline arzneimittel zur inhalation
WO2014016548A2 (en) *	2012-07-27	2014-01-30	Cipla Limited	Pharmaceutical composition
EP2906218B1 (en)	2012-10-09	2016-12-14	Boehringer Ingelheim International GmbH	Beta-2-adrenoceptor agonist for the treatment of cough

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4460581A (en) *	1982-10-12	1984-07-17	Boehringer Ingelheim Kg	(1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en)	1983-08-03	1986-02-18	Miles Laboratories, Inc.	Medicament inhalation device
IE59026B1 (en)	1985-07-30	1993-12-15	Glaxo Group Ltd	Devices for administering medicaments to patients
SE453566B (sv)	1986-03-07	1988-02-15	Draco Ab	Anordning vid pulverinhalatorer
SG45171A1 (en)	1990-03-21	1998-01-16	Boehringer Ingelheim Int	Atomising devices and methods
DE4318455A1 (de)	1993-06-03	1994-12-08	Boehringer Ingelheim Kg	Kapselhalterung
DE19536902A1 (de)	1995-10-04	1997-04-10	Boehringer Ingelheim Int	Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
CZ20023537A3 (cs)	2000-04-27	2003-02-12	Boehringer Ingelheim Pharma Kg	Betamimetika, způsob jejich výroby a použití jako farmaceutický prostředek
EP1326862B1 (de)	2000-10-12	2004-09-15	BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG	Kristallines monohydrat von tiotropiumbromid, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
IL159238A0 (en)	2001-06-22	2004-06-01	Boehringer Ingelheim Pharma	Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
DE10130371A1 (de) *	2001-06-23	2003-01-02	Boehringer Ingelheim Pharma	Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
ES2203327B1 (es) *	2002-06-21	2005-06-16	Almirall Prodesfarma, S.A.	Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
DE10230751A1 (de) *	2002-07-09	2004-01-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
DE10246374A1 (de) *	2002-10-04	2004-04-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10253282A1 (de) *	2002-11-15	2004-05-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

2005
- 2005-04-18 EP EP11187038.2A patent/EP2422786B1/de active Active
- 2005-04-18 EA EA200601846A patent/EA013157B1/ru active Protection Beyond IP Right Term
- 2005-04-18 PT PT05739576T patent/PT1781298E/pt unknown
- 2005-04-18 PL PL05739576T patent/PL1781298T4/pl unknown
- 2005-04-18 AU AU2005235419A patent/AU2005235419B2/en active Active
- 2005-04-18 ES ES11187038.2T patent/ES2523518T3/es active Active
- 2005-04-18 DK DK05739576.6T patent/DK1781298T3/da active
- 2005-04-18 SG SG200902525-5A patent/SG152237A1/en unknown
- 2005-04-18 AT AT05739576T patent/ATE539754T1/de active
- 2005-04-18 ES ES05739576T patent/ES2380370T3/es active Active
- 2005-04-18 WO PCT/EP2005/004073 patent/WO2005102349A1/de active Application Filing
- 2005-04-18 KR KR1020137011141A patent/KR20130049840A/ko not_active Application Discontinuation
- 2005-04-18 KR KR1020067024528A patent/KR101287460B1/ko active IP Right Grant
- 2005-04-18 NZ NZ550797A patent/NZ550797A/en unknown
- 2005-04-18 CA CA2559699A patent/CA2559699C/en not_active Expired - Fee Related
- 2005-04-18 PT PT111870382T patent/PT2422786E/pt unknown
- 2005-04-18 DK DK11187038.2T patent/DK2422786T3/da active
- 2005-04-18 SI SI200531488T patent/SI1781298T1/sl unknown
- 2005-04-18 BR BRPI0510080A patent/BRPI0510080B8/pt active IP Right Grant
- 2005-04-18 EP EP05739576A patent/EP1781298B1/de active Active
- 2005-04-18 PL PL11187038T patent/PL2422786T3/pl unknown
- 2005-04-18 SI SI200531904T patent/SI2422786T1/sl unknown
- 2005-04-18 JP JP2007508805A patent/JP2007533683A/ja active Pending
- 2005-04-19 UY UY28861A patent/UY28861A1/es not_active Application Discontinuation
- 2005-04-20 PE PE2005000432A patent/PE20060462A1/es active IP Right Grant
- 2005-04-20 MY MYPI20051739A patent/MY148945A/en unknown
- 2005-04-21 TW TW101108945A patent/TWI374739B/zh active
- 2005-04-21 TW TW094112735A patent/TWI372056B/zh active
- 2005-04-22 AR ARP050101601A patent/AR049262A1/es not_active Application Discontinuation
2006
- 2006-08-08 ZA ZA2006/06624A patent/ZA200606624B/en unknown
- 2006-08-24 IL IL177685A patent/IL177685A/en active IP Right Grant
- 2006-10-23 EC EC2006006947A patent/ECSP066947A/es unknown
- 2006-11-02 NO NO20065060A patent/NO337714B1/no active Protection Beyond IP Right Term
2012
- 2012-03-26 CY CY20121100308T patent/CY1113890T1/el unknown
2013
- 2013-05-26 IL IL226562A patent/IL226562A0/en unknown
2014
- 2014-11-07 CY CY20141100925T patent/CY1115719T1/el unknown
2015
- 2015-12-01 NL NL300779C patent/NL300779I2/nl unknown
- 2015-12-01 LT LTPA2015043C patent/LTC1781298I2/lt unknown
- 2015-12-01 HU HUS1500058C patent/HUS1500058I1/hu unknown
- 2015-12-01 BE BE2015C065C patent/BE2015C065I2/fr unknown
2016
- 2016-05-09 LU LU93066C patent/LU93066I2/fr unknown
- 2016-12-01 NO NO2016022C patent/NO2016022I1/no unknown
2017
- 2017-01-13 FI FIC20170005C patent/FIC20170005I1/fi unknown
- 2017-04-20 CY CY2017014C patent/CY2017014I1/el unknown

Also Published As

Publication number	Publication date
ES2523518T3 (es)	2014-11-26
TW201231055A (en)	2012-08-01
DK2422786T3 (da)	2014-11-17
ES2380370T3 (es)	2012-05-11
EA013157B1 (ru)	2010-02-26
BRPI0510080B1 (pt)	2020-08-18
HUS1500058I1 (hu)	2016-01-28
BE2015C065I2 (lt)	2024-08-08
ZA200606624B (en)	2008-01-08
PL1781298T3 (pl)	2012-06-29
WO2005102349A1 (de)	2005-11-03
SI1781298T1 (sl)	2012-04-30
NO337714B1 (no)	2016-06-06
KR20130049840A (ko)	2013-05-14
ATE539754T1 (de)	2012-01-15
EA200601846A1 (ru)	2007-04-27
EP2422786B1 (de)	2014-08-13
NO20065060L (no)	2006-11-21
NO2016022I2 (no)	2016-12-01
CY1115719T1 (el)	2017-01-25
TWI374739B (en)	2012-10-21
BRPI0510080A (pt)	2007-10-16
MY148945A (en)	2013-06-14
FIC20170005I1 (fi)	2017-01-13
KR20070015592A (ko)	2007-02-05
LU93066I2 (fr)	2016-07-11
NL300779I2 (nl)	2017-11-02
CA2559699C (en)	2012-06-19
AU2005235419A1 (en)	2005-11-03
IL177685A (en)	2013-10-31
NO2016022I1 (no)	2016-12-01
CA2559699A1 (en)	2005-11-03
SG152237A1 (en)	2009-05-29
NZ550797A (en)	2010-08-27
IL226562A0 (en)	2013-06-27
PT1781298E (pt)	2012-02-03
PL2422786T3 (pl)	2015-02-27
ECSP066947A (es)	2007-01-26
TWI372056B (en)	2012-09-11
CY2017014I2 (el)	2017-11-14
IL177685A0 (en)	2006-12-31
EP2422786A1 (de)	2012-02-29
EP1781298A1 (de)	2007-05-09
SI2422786T1 (sl)	2014-12-31
JP2007533683A (ja)	2007-11-22
DK1781298T3 (da)	2012-05-07
CY1113890T1 (el)	2016-07-27
PL1781298T4 (pl)	2017-07-31
UY28861A1 (es)	2005-11-30
PT2422786E (pt)	2014-11-12
AU2005235419B2 (en)	2010-11-04
AR049262A1 (es)	2006-07-12
BRPI0510080B8 (pt)	2021-05-25
PE20060462A1 (es)	2006-06-19
KR101287460B1 (ko)	2013-07-23
EP1781298B1 (de)	2012-01-04
CY2017014I1 (el)	2017-11-14

Publication	Publication Date	Title
LTC1781298I2 (lt)	2018-09-25	Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
DK1656347T3 (da)	2011-01-10	Substituerede indolderivater til farmaceutisk sammensætning til behandling af luftvejssygdomme
DK1937633T3 (da)	2010-10-11	Biphenyloxyeddikesyrederivater til behandling af respiratoriske sygdomme
DK1984357T3 (da)	2014-01-13	2,4-pyrimidindiaminforbindelser til behandling eller forebyggelse af autoimmunsygdomme
DK2474321T3 (da)	2019-06-03	Sammensætninger til behandling af collagenmedierede sygdomme
HK1166983A1 (zh)	2012-11-16	包含用於治療疾病或紊亂的化合物的固體形式，其組合物，及其用途
DK1817282T3 (da)	2011-10-10	Til behandling af respiratoriske sygdomme egnede phenoxy derivater
DK1940409T3 (da)	2010-11-29	Nye lægemiddelkombinationer til behandling af åndedrætssygdomme
AP2378A (en)	2012-03-08	Sulfonamide derivatives for the treatment of diseases.
IL181049A0 (en)	2007-07-04	Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
AP2359A (en)	2012-01-30	Sulfonamide derivatives for the treatment of diseases.
DK1962869T3 (da)	2013-06-24	Behandling af luftvejssygdomme
TW200738699A (en)	2007-10-16	4-Substituted pyrazoline compounds, their preparation and use as medicaments
WO2009071689A3 (de)	2009-07-23	5-halogen-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
CY2018006I1 (el)	2018-06-27	Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
IL192415A0 (en)	2008-12-29	Pharmaceutical composition for the treatment of nail diseases
DE602006005640D1 (de)	2009-04-23	4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
DK1856070T3 (da)	2011-09-26	Nye lægemidler til behandling af luftvejssygdomme
DK3072507T3 (da)	2021-02-08	Farmaceutiske sammensætninger til glukokortikoidsubstitutionsterapi
FI20095600A (fi)	2009-06-09	Koostumus ihosairauksien hoitoa varten
DE602006002608D1 (de)	2008-10-16	4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
ITRM20050179A1 (it)	2006-10-14	Composizione impiegabile per il trattamento delle patologie paradontali.
HU0500145D0 (en)	2005-04-28	Composition for the treatment of oral diseases
SE0400575D0 (sv)	2004-03-05	A novel pharmacentical composition for the treatment of skin conditions
TWI350171B (en)	2011-10-11	Pharmaceutical compositions for treatment of cardio-cerebral-vascular diseases